Search Results

Filter
  • 1-10 of  3,493,646 results for ""UNITED States""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

FDA Approval and Regulation of Pharmaceuticals, 1983-2018.

  • Authors : Darrow JJ; Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.; Avorn J

Subjects: Government Regulation* ; United States Food and Drug Administration*; Drug Approval/Drug Approval/Drug Approval/*legislation & jurisprudence

  • Source: JAMA [JAMA] 2020 Jan 14; Vol. 323 (2), pp. 164-176.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160

Record details

×
Academic Journal

Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system.

  • Authors : Cross RK; University of Maryland School of Medicine, Baltimore, Maryland, United States of America.; Chiorean M

Subjects: Adverse Drug Reaction Reporting Systems* ; United States Food and Drug Administration*; Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/Antibodies, Monoclonal, Humanized/*adverse effects

  • Source: Plos One [PLoS One] 2019 Dec 04; Vol. 14 (12), pp. e0225572. Date of Electronic Publication: 20191204 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081

Record details

×
Editorial & Opinion

Joint statement on EPA proposed rule and public availability of data (2019).

  • Authors : Thorp HH; Editor-in-Chief, Science family of journals, Washington, District of Columbia, United States of America.; Skipper M

Subjects: Information Dissemination/Information Dissemination/Information Dissemination/*ethics ; United States Environmental Protection Agency/United States Environmental Protection Agency/United States Environmental Protection Agency/*ethics ; United States Environmental Protection Agency/United States Environmental Protection Agency/United States Environmental Protection Agency/*legislation & jurisprudence

  • Source: Plos Medicine [PLoS Med] 2019 Nov 26; Vol. 16 (11), pp. e1003014. Date of Electronic Publication: 20191126 (Print Publication: 2019).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101231360

Record details

×
Academic Journal

Association Between Medicare and FDA Policies and Prior Authorization Requirements for Buprenorphine Products in Medicare Part D Plans.

Subjects: Government Regulation* ; Insurance Coverage* ; Medicare Part D*/Medicare Part D*/Medicare Part D*/legislation & jurisprudence

  • Source: JAMA [JAMA] 2019 Jul 09; Vol. 322 (2), pp. 166-167.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160

Record details

×
Academic Journal

Effectiveness and safety of direct oral anticoagulants compared to warfarin in treatment naïve non-valvular atrial fibrillation patients in the US Department of defense population.

  • Authors : Gupta K; Bristol-Myers Squibb, Lawrenceville, NJ, USA.; Trocio J

Subjects: United States Department of Defense*; Anticoagulants/Anticoagulants/Anticoagulants/*administration & dosage ; Atrial Fibrillation/Atrial Fibrillation/Atrial Fibrillation/*drug therapy

  • Source: BMC Cardiovascular Disorders [BMC Cardiovasc Disord] 2019 Jun 13; Vol. 19 (1), pp. 142. Date of Electronic Publication: 2019 Jun 13.Publisher: BioMed Central Country of Publication: England NLM ID: 100968539 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2261

Record details

×
Academic Journal

Communication of Nonefficacy Benefits of New Drugs Approved on the Basis of Noninferiority Trials Alone: Cohort Study of FDA and Sponsor Communication, 2011-2017.

  • Authors : Doshi P; Department of Pharmaceutical Health Services Research, University of Maryland School of Pharmacy, Baltimore, Maryland.; Spence O

Subjects: Communication* ; Drug Approval* ; Drug Industry*

  • Source: JAMA Internal Medicine [JAMA Intern Med] 2019 May 01; Vol. 179 (5), pp. 719-721.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534

Record details

×
Academic Journal

Lessons From the Long and Winding Road to Medicare for All.

  • Authors : Oberlander J; The author is with the Department of Social Medicine, School of Medicine, and Department of Health Policy & Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill.

Subjects: Politics*; Medicare/Medicare/Medicare/*trends ; National Health Insurance, United States/National Health Insurance, United States/National Health Insurance, United States/*trends

  • Source: American Journal Of Public Health [Am J Public Health] 2019 Nov; Vol. 109 (11), pp. 1497-1500. Date of Electronic Publication: 2019 Sep 19.Publisher: American Public Health Association Country of Publication: United States NLM ID: 1254074

Record details

×
Academic Journal

Progressive Tinnitus Management at Two Veterans Affairs Medical Centers: Clinical Implementation With Modified Protocols.

  • Authors : Beck JE; Audiology and Speech Pathology Service, Charles George Veterans Affairs Medical Center, Asheville, North Carolina.; Zaugg TL

Subjects: United States Department of Veterans Affairs*/United States Department of Veterans Affairs*/United States Department of Veterans Affairs*/organization & administration; Tinnitus/Tinnitus/Tinnitus/*therapy; Clinical Protocols

  • Source: American Journal Of Audiology [Am J Audiol] 2019 Apr 22; Vol. 28 (1S), pp. 162-173.Publisher: American Speech-Language-Hearing Association Country of Publication: United States NLM ID:

Record details

×
Academic Journal

Evaluation of the Inclusion of Studies Identified by the FDA as Having Falsified Data in the Results of Meta-analyses: The Example of the Apixaban Trials.

  • Authors : Garmendia CA; Office of Bioresearch Monitoring Operations, Office of Regulatory Affairs, US Food and Drug Administration, Miami, Florida.; Nassar Gorra L

Subjects: United States Food and Drug Administration*; Clinical Trials as Topic/Clinical Trials as Topic/Clinical Trials as Topic/*methods ; Drug Approval/Drug Approval/Drug Approval/*methods

  • Source: JAMA Internal Medicine [JAMA Intern Med] 2019 Apr 01; Vol. 179 (4), pp. 582-584.Publisher: American Medical Association Country of Publication: United States NLM ID: 101589534

Record details

×
Academic Journal

Workplace health promotion and safety in state and territorial health departments in the United States: a national mixed-methods study of activity, capacity, and growth opportunities.

  • Authors : Linnan LA; Center for Health Promotion and Disease Prevention, University of North Carolina at Chapel Hill, 1700 M.L.K. Jr Blvd, CB#7426, Chapel Hill, NC, 27514, USA. .; Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, 135 Dauer Drive, CB# 7440, Chapel Hill, NC, 27599, USA. .

Subjects: Occupational Health* ; Public Health Administration* ; United States Occupational Safety and Health Administration*

  • Source: BMC Public Health [BMC Public Health] 2019 Mar 12; Vol. 19 (1), pp. 291. Date of Electronic Publication: 2019 Mar 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458

Record details

×
  • 1-10 of  3,493,646 results for ""UNITED States""